Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-009269
Filing Date
2018-05-10
Accepted
2018-05-09 18:25:13
Documents
59
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20180331_10q.htm 10-Q 1019520
2 EXHIBIT 10.2 ex_111948.htm EX-10.2 20590
3 EXHIBIT 31.1 ex_111771.htm EX-31.1 11151
4 EXHIBIT 31.2 ex_111772.htm EX-31.2 9751
5 EXHIBIT 32.1 ex_111773.htm EX-32.1 6944
  Complete submission text file 0001437749-18-009269.txt   3822812

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acrx-20180331.xml EX-101.INS 680900
7 XBRL TAXONOMY EXTENSION SCHEMA acrx-20180331.xsd EX-101.SCH 47367
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20180331_cal.xml EX-101.CAL 33116
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20180331_def.xml EX-101.DEF 250021
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20180331_lab.xml EX-101.LAB 212066
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20180331_pre.xml EX-101.PRE 270967
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 18819904
SIC: 2834 Pharmaceutical Preparations